Wits Clinical Research

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Prostate cancer2 trials

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• Pfizer2 trials

Running trials

• Active, not recruiting

  Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

  NCT04821622· Phase 3· Pfizer· Source

• Active, not recruiting

  Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC

  NCT03395197· Phase 3· Pfizer· Source